With regard to the aging population and availability of effective interventions, especially intravitreal anti-vascular endothelial growth factor drugs, macular degeneration may be recognized as an important public eye health issue for future planning (Jonas et al. 2014). The gene discussed is VEGFA; the disease is macular degeneration.